Background: Childhood asthma is likely the result of gene-byenvironment (G 3 E) interactions. Dust mite is a known risk factor for asthma morbidity. Yet, there have been no genome-wide G 3 E studies of dust mite allergen on asthmarelated phenotypes. Objective: We sought to identify genetic variants whose effects on lung function in children with asthma are modified by the level of dust mite allergen exposure. Methods: A genome-wide interaction analysis of dust mite allergen level and lung function was performed in a cohort of Puerto Rican children with asthma (Puerto Rico Genetics of Asthma and Lifestyle [PRGOAL] ). Replication was attempted in 2 independent cohorts, the Childhood Asthma Management Program (CAMP) and the Genetics of Asthma in Costa Rica Study. Results: Single nucleotide polymorphism (SNP) rs117902240 showed a significant interaction effect on FEV 1 with dust mite allergen level in PRGOAL (interaction P 5 3.1 3 10
28
), and replicated in the same direction in CAMP white children and CAMP Hispanic children (combined interaction P 5 .0065 for replication cohorts and 7.4 3 10 29 for all cohorts). Rs117902240 was positively associated with FEV 1 in children exposed to low dust mite allergen levels, but negatively associated with FEV 1 in children exposed to high levels. This SNP is on chromosome 8q24, adjacent to a binding site for CCAAT/enhancer-binding protein beta, a transcription factor that forms part of the IL-17 signaling pathway. None of the SNPs identified for FEV 1 /forced vital capacity replicated in the independent cohorts. Conclusions: Dust mite allergen exposure modifies the estimated effect of rs117902240 on FEV 1 in children with asthma. Analysis of existing data suggests that this SNP may have transcription factor regulatory functions. (J Allergy Clin Immunol 2017;140:996-1003.)
Key words: Childhood asthma, lung function, dust mite allergen, genome-wide interaction study, gene-by-environment interactions, CEBPb Asthma, the most common noncommunicable chronic illness among children, 1 has an estimated heritability of up to 50% to 90%. 2, 3 Although dozens of genes that confer susceptibility to asthma or asthma morbidity have been recently identified, 4 single nucleotide polymorphisms (SNPs) in such genes account for as little as 10% to 50% of the disease's heritability. One potential reason for this ''missing heritability'' is gene-by-environment interactions because certain genetic variants may confer risk only in the presence of certain environmental exposures.
One of the best characterized environmental risk factors for asthma morbidity is exposure to indoor allergens. In particular, dust mite allergen is known to increase the risk of asthma exacerbations, and to increase airway responsiveness while reducing lung function. [5] [6] [7] The cysteine proteases in dust mites' fecal particles are potent inducers of allergic sensitization, 8 and exposure to house dust mite can also trigger a direct, nonallergic, inflammatory reaction. 9 Both interventions to reduce dust mite exposure 10, 11 and trials of immune therapy to induce dust mite tolerance [12] [13] [14] have been shown to improve asthma symptoms or reduce morbidity from asthma.
Few studies have looked at the effect of the interaction between genetic variants and allergens on asthma. Gene-by-allergen interactions have been reported for dust mite and several candidate genes for asthma, including IL10, 15 TGFB1, 16 or the purinergic receptor P2Y, G-protein coupled 12 (P2RY12). 17 More recently, a study using genome-wide expression in vitro responses to dust mite allergen reported that IL9 may interact with environmental dust mite allergen and increase severe asthma exacerbations. 18 In the present study, we performed a genome-wide interaction study of the effect of house dust mite allergen (Dermatophagoides pteronyssinus) level on lung function in Puerto Rican children with asthma, with replication studies in 2 independent cohorts of children with asthma.
METHODS

Study population
As part of a case-control study of childhood asthma in Puerto Ricans (Puerto Rico Genetics of Asthma and Lifestyle [PRGOAL]), we recruited 618 children with asthma (defined as physician-diagnosed asthma and at least 1 episode of wheeze in the previous year) living in Hartford (Conn) and San Juan (Puerto Rico). The details of subject recruitment have been published previously. [19] [20] [21] In brief, from September 2003 to July 2008, flyers were distributed to all parents of children in grades K-8 in 15 public elementary/middle schools in Hartford, Conn, that enroll a high proportion (42% to 94%) of Puerto Rican children. Of 640 children whose parents were interested in the study, 585 (91.4%) were eligible after screening; parents of 449 (76.7%) of these 585 children (including 267 children with asthma and 182 control subjects) agreed to participate. There were no significant differences in age, sex, or area of residence between eligible children who did (n 5 449) and did not (n 5 136) participate. From March 2009 to June 2010, children were recruited from households in metropolitan San Juan, Puerto Rico, selected using a multistage probability sample design. Primary sampling units were randomly selected neighborhood clusters based on the 2000 US census, and secondary sampling units were randomly selected households within each primary sampling unit. A household was eligible if 1 or more resident was a child 6 to 14 years old. In households with more than 1 eligible child, 1 child was selected for screening; in households with multiple eligible children, 1 child was randomly selected using Kish tables. Of 6401 contacted households, 1111 had 1 or more child within the study age range who met other inclusion criteria. To reach our target sample size (> _700 children), we attempted to enroll a random sample (n 5 783) of these 1111 children. Parents of 105 (13.4%) of these households refused to participate or could not be reached. There were no significant differences in age, sex, or area of residence between eligible children who did (n 5 678, including 351 children with asthma and 327 control subjects) and did not (n 5 105) participate. At both study sites, participants had to have 4 Puerto Rican grandparents and had to have lived in the same household for 1 or more year. Of the 618 children with asthma at both study sites, 520 (287 from San Juan and 233 from Hartford) had blood samples and sufficient DNA for genome-wide genotyping. Of these 520 children, 440 (84.6%, 249 from San Juan and 191 from Hartford) also had data on indoor dust mite allergen level and lung function, and were thus included in the current analysis.
Ethics statement
Written consent was obtained from parents of participating children, from whom written assent was also obtained. 
Lung function
Spirometry was performed in participating children using an EasyOne spirometer (NDD Medical Technologies, Andover, Mass). Subjects had to be free of respiratory infections for 4 or more weeks before testing, and they were also instructed (when possible) to avoid the use of inhaled short-and longacting bronchodilators for 4 or more hours and 12 or more hours before testing, respectively. Expiratory maneuvers were judged acceptable if they met or exceeded American Thoracic Society criteria for children. 22 The best FEV 1 and forced vital capacity (FVC) values from each test were selected for data analysis.
Dust mite allergen measurement
Dust samples were obtained from 3 areas in the home: the one in which the child slept (usually his or her bedroom), the living room/television room, and the kitchen. The dust was sifted through a 50-m-mesh metal sieve, and the fine dust was reweighed, extracted, and aliquoted for analysis of dust mite allergen (D pteronyssinus [Der p 1], hereinafter referred to as ''dust mite'') using mAb Multiplex assays that used the same reagents as the established ELISA. 23, 24 Dust mite allergen level was categorized as less than 2 mg/g versus 2 mg/g or more, because of known effects on allergic sensitization, distribution of allergen levels across the study cohorts (see Table I ), and ease of exposition. 6 
Genotyping
Details of genotyping in PRGOAL have been previously described. 21, 25 In brief, genotyping was performed using the Illumina HumanOmni2.5 BeadChip platform (Illumina, Inc, San Diego, Calif), which includes approximately 2.5 million SNPs. Subjects with a call rate of less than 95% were removed from the analysis. SNPs were removed if they were not in Hardy-Weinberg equilibrium (P < 10 26 ) in control subjects, had minor allele frequency lower than 1%, or had a failure rate greater than 5%. After all subject and marker quality control steps were completed, we had approximately 1.83 million SNPs available for data analysis. In addition, SNPs not directly genotyped in the top region(s) of interest were imputed using all populations from the 1000 Genomes Project (phase I v3) 26 as reference for phasing and imputation with SHAPE-IT 27 and IMPUTE2, 28 respectively.
Replication populations
We attempted replication in 2 cohorts of children with asthma: the Childhood Asthma Management Program (CAMP) and the Genetics of Asthma in Costa Rica Study (GACRS).
CAMP was a clinical trial of asthma therapy in 1041 children. Details on study population, subject recruitment, and study procedures have been previously published. 29, 30 In this analysis, we included 497 non-Hispanic white children and 56 Hispanic children who had genome-wide genotypic data, Der p 1 level in house dust, and lung function. Genotyping in CAMP was performed using the Illumina HumanHap550v3 BeadChip, and imputation was performed on the basis of 1000 Human Genomes Project 26 as previously described. 31 The GACRS was a cross-sectional study of 616 children with asthma and their parents. Details on study population, subject recruitment, and study procedures have been previously published. 32 In this analysis, we included 549 children who had genome-wide genotypic data, Der p 1 level in house dust, and lung function. Genotyping in the GACRS was performed using the Illumina BeadStation 500G platform, and imputation was performed on the basis of 1000 Human Genomes Project, 26 using the same methodology as in CAMP. In both CAMP and the GACRS, Der p 1 level in house dust was measured using the same approach as in the discovery cohort (PRGOAL, see above).
Statistical analysis
Our main outcomes were FEV 1 and FEV 1 /FVC. FEV 1 was analyzed as absolute value in liters (adjusted for sex, age, and height); we decided not to use percent-predicted values because there are no validated predictive equations for Puerto Ricans or Costa Ricans. For CAMP, we used prerandomization lung function to avoid any potential treatment arm effects. Dust mite allergen level was dichotomized using the median level for our cohort (<2 vs > _2 mg of Der p 1 per gram [mg/g] of dust), a cutoff that has been previously associated with allergic sensitization to dust mite. 6 All multivariate analyses were conducted under the assumption of an additive genetic model, and included the main effect of the SNP, the main effect of dust mite allergen level, an interaction term (Genotype 3 Allergen), age, sex, study site (2 sites for PRGOAL and 8 sites for CAMP), and cohort-specific principal components to account for potential population stratification (8 for PRGOAL, 6 for CAMP, 4 for the GACRS); models for FEV 1 also included height and height squared.
Genome-wide statistical significance was set at a P value of less than 5 3 10
28 . The top 5 SNPs from the PRGOAL analysis for FEV 1 and FEV 1 / FVC were carried forward for replication in CAMP and the GACRS. For each cohort, replication was defined as a 1-tailed P value of less than .05, in the same direction of interaction as in the discovery cohort. Fisher combined P values (sum of logs method) were obtained for all cohorts and for the replication cohorts only. All genome-wide interaction analyses for dust mite allergen were performed using PLINK v1.07. 33 All other analyses were performed in R (version 3.1.3), using R-Studio (version 0.98.1103). Table I summarizes the baseline characteristics of all cohorts. PRGOAL and CAMP white participants were slightly older than CAMP Hispanic participants and those in the GACRS. There was a higher proportion of boys in CAMP Hispanics (;69%) than in the other study groups (;56% to 60%). All children had similar lung function measures after adjusting for sex and age. Compared with PRGOAL, CAMP had a lower proportion of households with dust mite allergen level of more than 2 mg/g, whereas the GACRS had a higher proportion of households with dust mite allergen level of more than 2 mg/g than did the other cohorts. Table II . SNP rs117902240, located on chromosome 8q24.13, had a significant interaction with dust mite allergen level (P for interaction 5 3.1 3 10 28 ), while the P values for the other 4 SNPs ranged from 1.3 3 10 27 to 5.4 3 10
RESULTS
27
. Minor allele frequencies for the top 5 SNPs ranged from 1.3% to 9%. Table III presents the results of the replication efforts for FEV 1 . Of the 5 SNPs carried forward for replication, SNP rs117902240 was associated with FEV 1 among non-Hispanic whites (P value 5 .05) and Hispanics (P 5 .01) in CAMP, but not in the GACRS. The combined P value for all 3 replication cohorts (in CAMP and the GACRS) was .0065, and the combined P value for interaction with dust mite in all 4 cohorts was 7.4 3 10
29
. Given differences in sample sizes and effect estimates among cohorts, we also combined P values using a weighted approach: when weighted by the square root of the sample sizes, the combined P value was 1.1 3 10
24
; when weighted by the effect sizes, the combined P value was 3.0 3 10
211
. Of the remaining 4 SNPs, 3 were associated with FEV 1 in the GACRS (rs1404568 and rs35312258 in chromosome 3, and rs72716237 in chromosome 9), but the direction of the estimated interactions with dust mite allergen was opposite that found in PRGOAL.
Using imputed SNP data based on the 1000 Human Genomes Project, we performed fine mapping of the region surrounding the top SNP (rs117902240): several SNPs showed an R 2 value of approximately 0.4 with this SNP; the top interaction P value for these imputed SNPs was 2.6 3 10 26 (rs186935901 and rs10108856), with others ranging from 1.3 3 10 24 to 9.5 3 10 24 (Fig 2) . Fig E1 in ) in children exposed to low dust mite allergen levels, but negatively associated with , and principal components. Boldface indicates genomewide significant (interaction P < 5 3 10
28
). A1, Minor allele; A2, major allele; b, beta coefficient for interaction term; BP, base position; CHR, chromosome; MAF, minor allele frequency; n(A1), number of subjects with at least 1 copy of the minor allele and low/high dust mite exposure; P value, interaction P value.
J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 4 FEV 1 in children exposed to high dust mite allergen levels (b 5 20.41 [0.13]; P 5 .003). Fig 3 shows the boxplot for FEV 1 , stratified by dust mite level and rs117902240 genotype. Table E1 in this article's Online Repository at www.jacionline. org presents further details for the stratified analysis of rs117902240 and the other top SNPs.
In an exploratory analysis, we assessed the biological plausibility of SNP rs117902240 as an allelic variant interacting with dust mite allergen. Using data from ENCODE 35 and is-rSNP, 36 a software designed to predict whether an SNP has a regulatory effect on transcription factor binding sites in silico, we found that SNP rs117902240 is less than 1 kb away from a transcription factor binding island identified in ENCODE using chromatin immunoprecipitation and DNA sequencing. Transcription factor CCAAT/enhancer-binding protein beta (CEBPb) binds in this region in human lung fibroblasts (ENCODE accession ENCSR000EFM). CEBPb forms part of the signaling pathway of IL-17, IL-6, nuclear factor kappa B, and IFN-g (see Fig 4) . 37, 38 Details for the other top SNPs may be found in this article's Online Repository at www.jacionline.org.
Finally, we explored SNPs within previously reported genes (IL9, IL10, TGFb1, P2RY2) for nominal association (1-tailed P value < .05) with FEV 1 . Several SNPs within these genes showed nominal associations, either for the main effect of genotype or for the Genotype 3 Dust Mite interaction (see Table E2 in this article's Online Repository at www.jacionline.org).
FEV 1 /FVC
The top 5 SNPs for FEV 1 /FVC are presented in Table E3 in this article's Online Repository at www.jacionline.org and the replication results are presented in Table E4 in this article's Online .098
Models included the main effects of genotype (additive) and dust mite allergen level (dichotomized <2 vs > _2 mg/g) and the interaction term (Genotype 3 Dust Mite Allergen Level), and were additionally adjusted for age, sex, study site, height, height 2 , and principal components. Boldface text is significant after multiple comparisons correction. A1, Minor allele; b, beta coefficient for interaction term; MAF, minor allele frequency; n, number of subjects with at least 1 copy of the minor allele and low/high dust mite exposure; NA, not available (genotyped or imputed); P value, interaction P value.
FIG 2.
Regional association plot for SNP rs117902240. Regional association plot generated using the LocusZoom tool from the Abecasis lab at the University of Michigan (http://locuszoom.sph.umich.edu/ locuszoom/), 34 with data imputed from the 1000 Genomes populations (phase I v3).
Repository at www.jacionline.org. One SNP (rs115997623) was associated in the GACRS and 1 (rs78930606) in CAMP whites, but both in opposite directions as in PRGOAL. None of the top SNPs for FEV 1 /FVC had significant combined P values for the replication cohorts.
DISCUSSION
In this study, we report that dust mite allergen level significantly modifies the estimated effect of 1 SNP (rs117902240) on FEV 1 in children with asthma. To our knowledge, this is the first study to examine a gene-by-allergen interaction on an asthmarelated phenotype (in this case, lung function) using a genomewide approach.
Dust mite exposure and sensitization have been widely reported as risk factors for asthma symptoms and exacerbations in affected individuals. 5, 6, 39, 40 Previous gene-by-environment studies of candidate genes have reported that dust mite exposure modifies the effects of IL9 and IL10 polymorphisms on asthma exacerbations, 15, 18 TGFb1 variants on asthma severity, 16 or purinergic receptor gene P2Y, G-protein coupled, 12 haplotypes on lung function. 17 Our results extend current knowledge on the topic by identifying novel polymorphisms using a genome-wide approach.
Using data from ENCODE 35 and is-rSNP, 36 we found that rs117902240 is closely adjacent to a transcription factor island that binds CEBPb, which forms part of the IL-17 signaling pathway (Fig 4) . IL-17A or IL-17F can stimulate the nuclear factor kappa B pathway, which, in turn, acts with CEBPb to activate target gene transcription in the nucleus. 38 IL-17 has been amply implicated in the pathogenesis of asthma, [41] [42] [43] and studies in dust mite-sensitized subjects have shown that specific immunotherapy can lead to reductions in IL-17 levels that correlate with symptom reduction. 44 However, CEBPb also participates in several other pathways, including IL-4, IL-6, TNF-a, and IFN-g signaling pathways, and it has been implicated in airway epithelium differentiation during lung development. 45 Thus, functional studies will be needed to determine the precise role of CEBPb in the effect of the interaction between dust mite and genotype on lung function in asthma.
Children with more severe or poorly controlled asthma have worse lung function. 46 Moreover, poor lung function in children with asthma predicts exacerbations over subsequent followup, 47 and is associated with worse outcomes in adulthood. 48 Several studies (including genome-wide association study and candidate-gene studies) have been performed to identify genetic variants associated with lung function in subjects with asthma, [49] [50] [51] regardless of allergen exposure. Of note, however, the top SNP reported here would have been missed in a ''regular'' genome-wide association study, but had significant (and opposite) effects when stratified by level of dust mite allergen exposure. This has potential implications, both in terms of improving our understanding of the underlying mechanisms by which dust mite impacts lung function and also in terms of developing new CEBPb is one of the mediators of IL-17A and IL-17F signaling pathways, as well as nuclear factor kappa B signaling. 37, 38 CEBPb is also involved in IL-4, IL-6, and other signaling pathways (not shown). ERK, Extracellular signalregulated kinase; GSK3b, glycogen synthase kinase 3 beta; NFkB, nuclear factor kappa B; TAK1, transforming growth factor beta 1-activated kinase 1; TRAF-6, Tumor necrosis factor receptor-associated factor 6. approaches to identify susceptibility variants for asthma-related phenotypes.
Our study has several strengths, including the overall sample size of approximately 1550 children with asthma and data on dust mite allergen and lung function, and the biological plausibility of the top SNP based on ENCODE data. It also has several limitations: some of the SNPs examined had low minor allele frequencies and thus we had small sample size within some of the Genotype 3 Allergen Level strata, which may have led to low power to detect modest interactions. Post hoc analysis based on results from SNP rs117902240 shows that we had sufficient statistical power (see Table E5 in this article's Online Repository at www.jacionline.org) and the SNP 3 Dust Mite Exposure Level interaction replicated in the same direction in 3 out of 4 populations; nonetheless, results based on small strata must be interpreted with caution and should be further validated in future, prospective studies. In addition, we used statistical methods to adjust for population stratification but these may not be sufficient and some residual stratification may remain unaccounted for. Moreover, the choice of method for combining P values had an important impact on the results; different approaches yielded combined P values ranging from 1.1 3 10
24 (weighted by sample size), to 7.4 3 10 29 (Fisher unweighted method), to 3.0 3 10
211
(weighted by effect size). Finally, the timing and duration of dust mite exposure may be important factors in the pathogenesis of asthma, in addition to the level of the allergen. 52 In summary, we show that dust mite allergen exposure modifies the estimated effect of an SNP on a key measure of lung function (FEV 1 ) in children with asthma. Analysis of existing data suggests possible transcription factor regulatory functions for this SNP; future studies should focus on the functional validation of these pathways.
Clinical implications: The effect of certain genetic polymorphisms on lung function in children with asthma varies depending on their dust mite allergen exposure level. Future studies should assess whether personalized interventions for these children have a greater impact on lung function.
FEV 1 -FUNCTIONAL ANALYSIS OF SNPs rs117902240, rs72716237, AND rs35312258
Using data from ENCODE E1 and is-rSNP, E2 a software designed to predict in silico whether an SNP has a regulatory effect on transcription factor binding sites, we found that although SNP rs117902240 in chromosome 8q24.13 is intergenic, it lies within less than 1 Kbp from a transcription factor binding island identified in ENCODE using chromatin immunoprecipitation and DNA sequencing. Transcription factor C/EBP-beta binds in this region in human lung fibroblasts (ENCODE accession ENCSR000EFM) and forms part of the signaling pathway of IL-17, nuclear factor kappa B, and IFN-g (see Fig 3) . E3,E4 SNP rs72716237, in chromosome 9p21.2, lies right outside (<200bp) a transcription factor binding site for Maf bZip transcription factor K (MAFK) (ENCODE accession ENCS-R000EFH), whose expression can be induced by TGF-b. E5 MAFK regulates the expression of nuclear factor kappa B E6 and NF-E2-related factor 2, implicated in antioxidant pathways. E7 Of note, MAFK and NF-E2-related factor 2 may also regulate cystic fibrosis transmembrane conductance regulator gene expression. E8 SNP rs35312258, in chromosome 3q24, is an intronic SNP in gene SLC9A9 (solute carrier family 9, subfamily A, member 9), a Na1/H1 transmembrane exchanger that has been linked to autism and attention deficit/hyperactivity disorder, E9 and more recently to increased arterial stiffness. Table I ), an exposure proportion of 48.4% (Table I) , and risk allele frequency of 0.015 (rs117902240 , Table II) , with N 5 440, and based on the observed main effects of the additive SNP and dust mite level as well as their interaction, using a 2-sided test (null: no significant interaction).
